Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary (2013)
Chapter: Appendix C: Registered Workshop Attendees
Appendix C
Registered Workshop Attendees
Olusoji Adeyi
Sector Manager
World Bank
Vincent Ahonkhai
Senior Regulatory Affairs Officer
Gates Foundation
Sarah Alphs
Research Associate
The William Davidson Institute at the University of Michigan
Rifat Atun
Professor of International Health Management
Imperial College London
Jim Barrington
Global Progam Director
Novartis
Amy Bloom
Acting Chief, Infectious Diseases Division
USAID
Barry Bloom
Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health
Harvard School of Public Health
Anthony Boni
Pharmaceutical Specialist
USAID
Gail Cassell
Visiting Professor
Harvard Medical School
Peter Cegielski
Team Leader for Drug-Resistant TB
U.S. Centers for Disease Control and Prevention
Consultant
FSG Social Impact Consultants
Gordon Comstock
Director, Global Supply Chain
Partnership for Supply Chain Management
Henk den Besten
Senior Supply Chain Advisor
Partnership for Supply Chain Management
Lucica Ditiu
Executive Secretary
World Health Organization, Stop TB Partnership
Suzanne Essama-Bibi
TB Technical Advisor
FHI 360
David Ferreira
Managing Director for Innovative Finance
GAVI Alliance
Gary Filerman
President
Atlas Health Foundation
Hamish Fraser
Assistant Professor of Medicine
Director of Informatics and Telemedicine
Partners In Health
Harvard Medical School
Anne Goldfeld
Professor of Medicine
Global Health Committee
Harvard Medical School
Jose Gomez-Marquez
Director
MIT Little Devices Lab
Andrew Gray
Senior Lecturer, Pharmaceutical Sciences
School of Health Sciences
University of KwaZulu-Natal
Carol Hamilton
Senior Scientist
FHI 360
Debra Hanna
Associate Director, CPTR
Critical Path Institute
Lisa Hedman
Project Manager
World Health Organization
Myriam Henkens
International Medical Coordinator
Médecins Sans Frontières
Brad Herbert
Managing Director
Brad Herbert Associates
Julia Hipps
Senior Director
Eli Lilly and Company
Maria Insua
Senior Technical Advisor
University Research Co., LLC
Douglas Keene
Vice President
Center for Pharmaceutical Management
Management Sciences for Health
Brazil Country Program Director
Management Sciences for Health
Salmaan Keshavjee
Director, Program in Infectious Disease and Social Change
Harvard Medical School
Michael Kimerling
Senior Program Officer, Tuberculosis Global Health Program
Bill & Melinda Gates Foundation
Jenna Kohnke
Program Manager
American Cancer Society
Paul Lalvani
Director and Dean
Empower School of Health
Patrick Lukulay
Vice President Global Health Impact Programs
USP
Robert Matiru
TB Portfolio Manager
UNITAID
World Health Organization
Montserrat Meiro-Lorenzo
Senior Public Health Specialist
World Bank
Thomas Moore
World Health Organization, Stop TB Partnership
Sana Mostaghim
MDR TB Drug Access Project Manager
Clinton Health Access Initiative
Betsy Myers
Program Director for Medical Research
Doris Duke Charitable Foundation
Norbert Ndjeka
MDR TB Director
Department of Health, South Africa
Meg O’Brien
Director, Global Access to Pain Relief Initiative
American Cancer Society
Christophe Perrin
QA Pharmacist International Union Against
Tuberculosis and Lung Disease
Claire Queresi
Senior Program Officer
Results for Development Institute (R4D)
Iain Richardson
Senior Director, Global Supply Chain and Logistics
Eli Lilly and Company
David Ripin
Executive Vice President of Access Programs and Chief Scientific Officer
Clinton Health Access Initiative
Program Manager
Partners In Health
Paul Ryu
Regional Manager of Western Europe
Dong-A Pharmaceutical Co., Ltd.
Nina Schwalbe
Managing Director, Policy and Performance
GAVI Alliance
Robert Sebbag
Vice President, Access to Medicines
Sanofi
Andreas Seiter
Senior Health Specialist
World Bank
Pooja Shaw
Program Officer
Results for Development Institute (R4D)
Tracy Sims
Vice President
Eli Lilly & Co. Foundation
Robert Stanley
Manager
Partnership for Supply Chain Management
Trish Stroman
Principal
The Boston Consulting Group
Jami Taylor
Senior Director, Global Access Policy
Janssen, The Pharmaceutical Companies of Johnson & Johnson
Cheri Vincent
TB Team Leader
USAID
Brenda Waning
Coordinator, Market Dynamics
UNITAID
World Health Organization
Prashant Yadav
Director, Healthcare Research Initiative
University of Michigan
Andre Zagorski
Principal Technical Advisor for TB, Center for Pharmaceutical
Management Management Sciences for Health
